Adaptimmune Presents Detailed Safety Update from Ongoing MAGE ... - GlobeNewswire (press release)

FierceBiotech
Adaptimmune Presents Detailed Safety Update from Ongoing MAGE ...
GlobeNewswire (press release)
Acceptable safety profile with no evidence of off-target toxicity in 100 million cell safety cohorts -. - Dosing continues with the one billion “target” cell dose -. PHILADELPHIA, Pa. and OXFORD, U.K., June 04, 2018 (GLOBE NEWSWIRE) -- Adaptimmune ...
Adaptimmune Therapeutics (ADAP) Announces Detailed Safety ...StreetInsider.comtodos os 5 artigos »